Globus Medical, NuVasive and a final agreement were reached to combine their businesses in an all-stock deal.
“This transaction reflects our mission to become the leading musculoskeletal technology company in the world by developing products that promote healing in patients with musculoskeletal disorders,” Dan Scavilla, president and CEO of Globus Medical, said in a company press release. “With NuVasive, we can help support more patients through leading innovation and expanding our commercial reach to provide superior service to our surgeon and hospital partners. We look forward.
